Siloam International Hospitals Tbk Pt operates within the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Siloam International Hospitals Tbk Pt with three other
health care providers in Asia:
Raffles Medical Group Limited
sales of 489.14 million Singapore Dollars [US$359.66 million]
of which 59%
was Hospital Services),
Samitivej Public Company Limited
(11.75 billion Thai Bahts [US$386.50 million]
of which 100%
was Hospital), and
Narayana Hrudayalaya Ltd
based in India
(22.81 billion Indian Rupees [US$320.01 million]
of which 100%
was Medical and Healthcare Services).
During the year ended December of 2018, sales at
Siloam International Hospitals Tbk Pt were 5.96 trillion Indonesian Rupiahs (US$425.88 million).
a very small
increase of 2.0%
versus 2017, when the company's sales were 5.85 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Siloam International Hospitals Tbk Pt
(and since 2013, sales have increased a total of 138%).
Sales of Sh Makassar saw an increase
that was more than double the company's growth rate: sales were up
10.0% in 2018, from
297.33 billion Indonesian Rupiahs to 327.10 billion Indonesian Rupiahs.
Siloam International Hospitals Tbk Pt also saw significant increases in sales in
Others (up 8.1% to 2.13 trillion Indonesian Rupiahs)
Sh Lippo Vilage (up 4.0% to 867.33 billion Indonesian Rupiahs)
Mrccc (up 4.7% to 614.46 billion Indonesian Rupiahs)
Sh Surabaya (up 7.2% to 409.78 billion Indonesian Rupiahs)
Not all segments of Siloam International Hospitals Tbk Pt experienced an increase in sales in 2018:
sales of Sh Denpasar fell 1.1% to 316.92 billion Indonesian Rupiahs.